MoTHER Buddy Program

Obesity Clinical Trial

Official title:

With Help From Buddies: The Impact of Social Support Using Mobile Technology on Physical Activity Among Women With Young Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02338765
• Other study ID #: A123858
• Status: Completed
• Phase: N/A
• First received: January 7, 2015
• Last updated: June 8, 2016
• Start date: January 2015
• Est. completion date: April 2016

Study information

• Verified date: June 2016
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of the 12-week study is to determine if competing a physical activity program with a buddy helps increase daily physical activity when compared to completing the same physical activity program without a buddy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 54
• Est. completion date: April 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 44 Years

Eligibility

Inclusion Criteria:

1. Physically inactive,

2. having at least one child aged less than 5 years,

3. having at least one family member or friend who can support physical activity engagement and reside in the same community,

4. having access to computer and phone, and

5. overweight/obese (Body Mass Index: 23 kg/m2 or more)

Exclusion Criteria:

1. Having known medical conditions that prevent regular physical activity and

2. current participation in other lifestyle modification programs

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Obesity
• Physical Activity

Intervention

Behavioral:
• mHealth Physical Activity

• Buddy-partnered exercise

Locations

Country	Name	City	State
United States	University of California, San Francisco	San Francisco	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, San Francisco	American Heart Association

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Daily steps		weekly during study period, up to 12 weeks	No
Secondary	Weight		Changes in weight over the 12-week study period	No
Secondary	Waist Circumference (WC)		Changes in WC over the 12-week study period	No
Secondary	Hip Circumference (HC)		Changes in HC over the 12-week study period	No